KRAS and cancer: A previous study demonstrated that individual neoantigen cancer vaccines can elicit responses against KRAS G12C and G12V mutations, and long PFS is associated with epitope spreading.97,175 Thus, epitope spreading has become an indispensable marker of vaccine effectiveness.